European Pharmaceutical Review

MARCH 1, 2024

UKRI highlighted that overall, these investments will “enhance the UK’s global competitiveness by supporting research and innovation that leads to new and disruptive biomanufacturing processes across the UK.” Curious about sustainability in pharmaceutical manufacturing and the supply chain?

Manufacturing 96

Manufacturing Pharmaceutical manufacturing Engineering Pharmaceutical 96

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Due diligence teams will focus on two key areas: the standard of the facilities and the pharmaceutical quality system.

Pharma 119

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 119

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Management 97

Management Food and Drug Administration Manufacturing Pharmaceutical manufacturing 97

pharmaphorum

JANUARY 24, 2023

Over the last 25 years, the headcount in the medicines manufacturing sector has fallen by 7,000 and since 2009 production volumes have fallen by nearly a third (29%), suggesting “faltering attractiveness” of the UK for manufacturing. ” Image from the Association of the British Pharmaceutical Industry (ABPI).

Manufacturing 111

Manufacturing Medicine Government Pharmaceutical manufacturing 111

PharmaTech

AUGUST 30, 2023

In pursuit of increased competitiveness and bottom-line impact, pharmaceutical manufacturers face increasing pressure to fast-track technological innovation while maintaining regulatory compliance.

Manufacturing 52

Manufacturing Pharmaceutical manufacturing Competition Pharma 52

European Pharmaceutical Review

AUGUST 29, 2024

A major new £400 million public-private collaboration has launched in the UK, aimed at enhancing the life sciences sector’s economic growth and the competitiveness over the next five years. The innovative programme is set to strengthen clinical trials and improve medicine manufacturing in the UK.

Government 59

Government Pharma Competition Medicine 59

pharmaphorum

NOVEMBER 25, 2022

Having a healthy and sustainable pharmaceutical sector is both a necessary requirement and a good one for society. Alberto Chiesi deemed Italian pharmaceutical industries the “reference leaders in Europe”. Already, the effects of the Biotech Centre of Excellence are being felt, not least in the employment opportunities it will create.

Pharmaceutical 98

Pharmaceutical Manufacturing Medicine Competition 98

Impetus Digital

AUGUST 2, 2024

The pharmaceutical industry has numerous use cases for AI. Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. Regulatory Compliance Regulatory frameworks are continuously evolving in the pharmaceutical industry.

Pharma 94

Pharma Manufacturing Medicine Marketing 94

European Pharmaceutical Review

DECEMBER 6, 2023

Historically, pharmaceutical manufacturers have built sufficient capacity so that they can leverage sudden surges in demand. Track and trace is a fantastic way to protect the consumer, but from a pharmaceutical manufacturing standpoint, there is significant work needed to perfect that.

Manufacturing 98

Manufacturing Engineering Pharmaceutical manufacturing Pharmaceutical 98

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. 9 In particular, the option of CCU is not widely considered.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

European Pharmaceutical Review

NOVEMBER 8, 2022

3) policing anticompetitive settlements between competing drug manufacturers. European pharmaceutical companies targeting the US market should be aware of these pending bills and their potential impacts on market entry, intellectual property enforcement and payer access. 5) monitoring access to biosimilars.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

Commercial dose companies form a critical component of the pharmaceutical manufacturing industry’s value chain. The dose form manufacturing follows API manufacturing to produce the final dosage form (FDF such as tablets and injectables. Discover the leading commercial dose companies in contract marketing.

Leads 40

Leads Marketing Sales Management Manufacturing 40

Pharmaceutical Technology

NOVEMBER 25, 2022

For pharmaceutical manufacturers and contract manufacturing organizations (CMOs) with containment capabilities, this likely means a distinct advantage over those without. Dedicated manufacturers are investing heavily in these services, powered by client requirements. A revolutionary development.

Manufacturing 52

Manufacturing Safety Pharmaceutical manufacturing Pharmaceutical 52

PM360

SEPTEMBER 30, 2024

Pharmaceutical sustainability initiatives ensure the entire industry can navigate current challenges and harness advanced innovations for current and future growth. The pharmaceutical industry is currently under immense internal and external pressures. That said, pharmaceutical sponsors cannot do this alone.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

Pharmaceutical Technology

JULY 29, 2022

This is borne out of the fact that while nearly three-quarters are confident in the education and training for those in the pharma sector, just 64% are confident with the industry’s ability to source engineers against competition from other sectors. Manufacturing agility: Index score 6.5/10. R&D ecosystem - Index score 6.54/10.

Biopharma 59

Biopharma Manufacturing Government Engineering 59

Medico Reach

FEBRUARY 8, 2023

The pharmaceutical sector has witnessed a steep growth in recent times. The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. The pharmaceutical industry is no different.

Pharma 52

Pharma Medicine Marketing Prospecting 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region. This August, the Charleston Chamber Foundation won a competition ran by the US Department of Commerce, which will award an $8.4m-dollar

Medical 52

Medical Healthcare Healthcare Networking 52

Pharmaceutical Technology

JULY 28, 2022

Investing in areas that have demonstrated a good track record of success for similar companies is a simple way to reduce risk, but in 2022, companies should be careful of investing in overly populated life sciences clusters, which might be too competitive. appeared first on Pharmaceutical Technology.

Transportation 52

Transportation Education Marketing Networking 52

Contrarian Sales Techniques

FEBRUARY 26, 2023

The paper was presented at the International Conference on Pharmaceutical Research and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5%

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

PM360

APRIL 25, 2023

Although AbbVie’s patent for Humira officially expired in 2016, the legal and regulatory delays paused competition for Humira until 2023. pharmaceutical industry. Financial incentives were explored further in the survey as biosimilars are expected to increase competition, thereby lower cost and increase access.

Marketing 97

Marketing Competition Government Manufacturing 97

Pharmaceutical Technology

MARCH 22, 2023

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. The skill sets are dynamic [in the pharmaceutical industry] and they change over time. It was a money-saving strategy that was paying off until Covid-19 hit.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Government Pharmaceutical 105

Pharmaceutical Technology

DECEMBER 19, 2022

While the ripple effect of such an event is expected across sectors, in the pharmaceutical arena, small and mid-sized enterprises (SMEs) are predicted to be heavily impacted as the economic downturn affects plans to raise capital, amongst other things. JP Morgan predicts that the US unemployment rate could rise to 4.3%

Pharmaceutical 69

Pharmaceutical Manufacturing Medicine Government 69

Pharmaceutical Technology

FEBRUARY 15, 2023

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised. But this results in huge, complex datasets.

Pharma 52

Pharma Pharmaceutical Manufacturing Medicine 52

Pharmaceutical Technology

FEBRUARY 3, 2023

Tablet manufacturing, which is the most common OSD form, takes an API dry powder ingredient and compresses it to form tablets, which can be coated or uncoated. Compared to other dosage forms, tablets are simpler to manufacture, package, and transport. Please check your email to download the Webinar.

Manufacturing 52

Manufacturing Transportation Pharmaceutical Pharmaceutical manufacturing 52

Clarivate

AUGUST 20, 2024

Top-line differences between list price and MFP obscure the impact of discounts and rebates that PBMs and MCOs can secure from manufacturers in exchange for coverage or preferred access. In highly competitive categories like diabetes, net price could be half of the list price.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52